Complications and Surveillance After Bariatric Surgery

Current Treatment Options in Neurology

Volumn 18, Issue 1, 2016, Pages 1-12

  Concors, Seth J ^a   Ecker, Brett L ^a   Maduka, Richard ^a   Furukawa, Alyssa ^a   Raper, Steven E ^a   Dempsey, Daniel D ^a   Williams, Noel N ^a   Dumon, Kristoffel R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bariatric surgery; Gastric bypass; Malnutrition; Micronutrients; Sleeve gastrectomy

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; IRON; NEUROLEPTIC AGENT; RETINOL; VITAMIN D;

ANASTOMOSIS LEAKAGE; ANEMIA; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BRAIN PSEUDOTUMOR; CARDIOVASCULAR DISEASE; COMORBIDITY; COPPER DEFICIENCY; DRUG ABSORPTION; DUMPING SYNDROME; EROSION; GASTRIC BANDING; GASTROESOPHAGEAL REFLUX; GASTROPLASTY; HAIR LOSS; HUMAN; INTERNAL HERNIA; IRON DEFICIENCY ANEMIA; JEJUNUM ULCER; LACTIC ACIDOSIS; MALABSORPTION; MALNUTRITION; METABOLIC SYNDROME X; MORTALITY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTOPERATIVE COMPLICATION; REVIEW; ROUX Y ANASTOMOSIS; SLEEP DISORDERED BREATHING; SLEEVE GASTRECTOMY; STENOSIS; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION; WOUND HEALING; ZINC DEFICIENCY;

EID: 84957942938     PISSN: 10928480     EISSN: 15343138     Source Type: Journal    
DOI: 10.1007/s11940-015-0383-0     Document Type: Review

References (48)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among us adults, 1999–2010. JAMA. 2012;307(5):491–7.
2. Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115(12):956–61.
3. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.
4. Ikramuddin S, Korner J, Lee W, et al. Roux-en-y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013;309(21):2240–9.
5. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: A randomized clinical trial. JAMA Surg. 2015;150(10):931–40.
6. Ryan DH, Johnson WD, Myers VH, Prather TL, McGlone MM, Rood J, et al. Nonsurgical weight loss for extreme obesity in primary care settings: results of the Louisiana Obese Subjects Study. Arch Intern Med. 2010;170(2):146–54.
7. Reames BN, Finks JF, Bacal D, Carlin AM, Dimick JB. Changes in bariatric surgery procedure use in Michigan, 2006–2013. JAMA. 2014;312(9):959–61.
8. Campos GM, Rabl C, Roll GR, et al. Better weight loss, resolution of diabetes, and quality of life for laparoscopic gastric bypass vs banding: results of a 2-cohort pair-matched study. Arch Surg. 2011;146(2):149–55.
9. DeMaria EJ. Bariatric surgery for morbid obesity. N Engl J Med. 2007;356(21):2176–83.
10. Iannelli A, Dainese R, Piche T, Facchiano E, Gugenheim J. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol: WJG. 2008;14(6):821–7.
11. Moy J, Pomp A, Dakin G, Parikh M, Gagner M. Laparoscopic sleeve gastrectomy for morbid obesity. Am J Surg. 2008;196(5):e56–9.
12. Bohdjalian A, Langer F, Shakeri-Leidenmühler S, Gfrerer L, Ludvik B, Zacherl J, et al. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and Ghrelin. Obes Surg. 2010;20(5):535–40. English. This is an important paper describing the outcomes after the VSG.
13. Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva-Datchary P, Myronovych A, Karns R, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature. 2014;509(7499):183–8.
14. O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA. Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg. 2013;257(1):87–94. This is an important outcome focused paper on the long term co-morbidity resolution resulting from bariatric surgery.
15. Tevis S, Garren M, Gould J. Revisional surgery for failed vertical-banded gastroplasty. Obes Surg. 2011;21(8):1220–4. English.
16. Prachand VN, DaVee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI ≥50kg/m(2)) compared with gastric bypass. Ann Surg. 2006;244(4):611–9.
17. Booth H, Khan O, Prevost T, Reddy M, Dregan A, Charlton J, et al. Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study. Lancet Diabetes Endocrinol. 2014;2(12):963–8.
18. Dorman R, Abraham A, Al-Refaie W, Parsons H, Ikramuddin S, Habermann E. Bariatric surgery outcomes in the elderly: an ACS NSQIP study. J Gastrointest Surg. 2012;16(1):35–44. English.
19. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.
20. Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.
21. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.
22. Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA. 2015;313(1):62–70.
23. Sugerman HJ, Felton 3rd WL, Salvant Jr JB, Sismanis A, Kellum JM. Effects of surgically induced weight loss on idiopathic intracranial hypertension in morbid obesity. Neurology. 1995;45(9):1655–9.
24. Sugerman HJ, Felton WL, Sismanis A, Kellum JM, DeMaria EJ, Sugerman EL. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg. 1999;229(5):634.
25. Aurora A, Khaitan L, Saber A. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc. 2012;26(6):1509–15. English.
26. Smith MD, Adeniji A, Wahed AS, Patterson E, Chapman W, Courcoulas AP, et al. Technical factors associated with anastomotic leak after Roux–en–Y gastric bypass. Surg Obes Relat Dis. 2015;11(2):313–20.
27. Moon RC, Teixeira AF, Goldbach M, Jawad MA. Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center. Surg Obes Relat Dis. 2014;10(2):229–34.
28. Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc. 2007;21(7):1090–4. English.
29. Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract. 2005;20(5):517–25.
30. Carrodeguas L, Szomstein S, Zundel N, Lo Menzo E, Rosenthal R. Gastrojejunal anastomotic strictures following laparoscopic Roux-en-Y gastric bypass surgery: analysis of 1291 patients. Surg Obes Relat Dis. 2006;2(2):92–7.
31. Takata MC, Ciovica R, Cello JP, Posselt AM, Rogers SJ, Campos GM. Predictors, treatment, and outcomes of gastrojejunostomy stricture after gastric bypass for morbid obesity. Obes Surg. 2007;17(7):878–84.
32. Higa K, Ho T, Boone K. Internal hernias after laparoscopic Roux-en-Y gastric bypass: incidence. Treatment and prevention. Obes Surg. 2003;13(3):350–4. English.
33. Eid I, Birch DW, Sharma AM, Sherman V, Karmali S. Complications associated with adjustable gastric banding for morbid obesity: a surgeon’s guide. Can J Surg. 2011;54(1):61–6.
34. Brown WA, Egberts KJ, Franke-Richard D, Thodiyil P, Anderson ML, O’Brien PE. Erosions after laparoscopic adjustable gastric banding: diagnosis and management. Ann Surg. 2013;257(6):1047–52.
35. MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg. 1993;165(1):155–62.
36. Carter PR, LeBlanc KA, Hausmann MG, Kleinpeter KP, de Barros SN, Jones SM. Association between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(5):569–72.
37. Patterson EJ, Davis DG, Khajanchee Y, Swanström LL. Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc Other Interv Tech. 2003;17(10):1561–5. English.
38. Berger JR. The neurological complications of bariatric surgery. Arch Neurol. 2004;61(8):1185–9.
39. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8(9):544–56.
40. Shankar P, Boylan M, Sriram K. Micronutrient deficiencies after bariatric surgery. Nutrition. 2010;26(11–12):1031–7.
41. Tack J, Deloose E. Complications of bariatric surgery: dumping syndrome, reflux and vitamin deficiencies. Best Pract Res Clin Gastroenterol. 2014;28(4):741–9. This article reviews the many micronutrient deficiencies associated with Bariatric surgery.
42. Levinson R, Silverman JB, Catella JG, Rybak I, Jolin H, Isom K. Pharmacotherapy prevention and management of nutritional deficiencies post Roux-en-Y gastric bypass. Obes Surg. 2013;23(7):992–1000. Another excellent review of micronutrient deficiencies associated with bariatric surgery and their potential complications.
43. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc. 2006;81(10):1371–84.
44. Juhasz-Pocsine K, Rudnicki SA, Archer RL, Harik SI. Neurologic complications of gastric bypass surgery for morbid obesity. Neurology. 2007;68(21):1843–50.
45. Dahlquist NR, Perrault J, Callaway CW, Jones JD. d-lactic acidosis and encephalopathy after jejunoileostomy: response to overfeeding and to fasting in humans. Mayo Clin Proc. 1984;59(3):141–5.
46. Hamad GG, Helsel JC, Perel JM, Kozak GM, McShea MC, Hughes C, et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry. 2012;169(3):256–63.
47. Seaman JS, Bowers SP, Dixon P, Schindler L. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model. Psychosomatics. 2005;46(3):250–3.
48. Pournaras D, Footitt D, Mahon D, Welbourn R. Reduced phenytoin levels in an epileptic patient following Roux-en-Y gastric bypass for obesity. Obes Surg. 2011;21(5):684–5. English.